MPS Limited: Funding details for USD 16.5M Unbound Medicine acquisition
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 6.1 pts less than its Printing & Publication peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
MPS Limited's wholly-owned subsidiary MPS North America LLC is acquiring 100% of Unbound Medicine, Inc. (Delaware, USA) for USD 16.50 Million. Funding mix: USD 3M inter-company loan from AJE LLC, USD 1.94M from MPS Limited, INR 420M term loan from ICICI Bank at 7.85 percent, and USD 9.81M equity infusion from MPS Limited. Balance from internal accruals. MPS NA LLC stays 100 percent subsidiary.
Acquisition expands US footprint. Deal funded through internal accruals plus debt of about USD 16.5M. No change in shareholding structure.